Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22384
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antimetabolites, Antineoplastic/adverse effects/therapeutic use,Antineoplastic Agents, Phytogenic/adverse effects/therapeutic use,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Carcinoma, Small Cell/*drug therapy,Deoxycytidine/administration & dosage/adverse effects/*analogs &,derivatives/*therapeutic use,Female,Humans,Lung Neoplasms/*drug therapy,Male,Middle Aged,Taxoids/administration & dosage/adverse effects/*therapeutic use,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/22384
ISSN: 0169-5002
Link: http://www.ncbi.nlm.nih.gov/pubmed/12826319
http://ac.els-cdn.com/S0169500203001545/1-s2.0-S0169500203001545-main.pdf?_tid=dbe5efcafe991384c9c5d31d0c9df963&acdnat=1333614043_ac24223447da3315e81b892ab58472cd
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Skarlos-2003-Docetaxel and gemcit.pdf159.58 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons